Skip to main content

Table 2 Influence on complications

From: Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts

  Complication N No complication N  
Age 63.52 ± 18.44 33 58.47 ± 18.24 199 n.s.a
Gender (f/m) 20/13 33 97/102 199 n.s.b
ASA 2.24 ± 0.66 33 2.11 ± 0.72 199 n.s.c
Defect size 10.98 ± 14.48 33 13.28 ± 17.95 196 n.s.a
BMI 26.79 ± 5.41 33 26.45 ± 5.39 199 n.s.a
Cancellous/Synthetic bone 17/16 33 100/99 199 n.s.b
Smoker/Non-Smoker 10/23 33 49/150 199 n.s.b
Insurance status W/C/P 23.5 %/13.4 %/12.2 % 32 76.5 %/86.6 %/87.8 % 198 n.s.b
Healing rate 7 (21.2 %) 33 1 (0.5 %) 186 <0.0001b
Consolidation time (months) 4.79 ± 4.39 26 3.36 ± 2.64 185 0.02a
  1. Overview about the comparing parameters in patients with or without a complication, ffemale, m male, ASA physical status according to the American Society of Anesthesiologists, BMI body mass index, n.s. not significant. W employers mutual insurance association, C compulsory health insurance fund, P private health insurance fund. a t-Test, b χ 2-Test, c U-Test (Mann und Whitney)